COVID-19 News & Education

The latest news, research, and COVID-19 testing information from Labcorp

Latest articles from our blog

Group of people swimming and tubing in a pool

Summer vacation and gathering tips for our third summer of the COVID-19 pandemic

Summer is in full swing! We’ve compiled a few tips to help you feel even more confident in your gathering and travel plans this year.

Woman putting mask on child to protect from COVID-19

COVID-19 Antibody levels: More may be better

Since the beginning of the COVID-19 pandemic, there’s been a lot of talk about testing. Usually, people are referring to diagnostic testing performed with a nasal swab. However, another type of testing—one that requires a blood test and that you may not know about—has been around nearly the whole time.

That testing is for assessing antibody levels against SARS-CoV-2, the virus that causes COVID-19.

Routine testing for body fever on population during COVID-19 crisis

Demystifying “Flurona”: Dual Viral Infection Is More Common Than You May Think

Since the start of the year, you’ve undoubtedly been hearing more and more about “Flurona.” You may be asking yourself, “Is this even possible? Why are we seeing this now? What can I do to protect myself and my loved ones?” 

people map

Why Viral Variants Like Omicron Are Emerging: A Viral Variation 101

When the COVID-19 pandemic started, we had a singular enemy: the SARS-CoV-2 virus. However, now it seems that there are multiple enemies, with the emergence of variants like Delta and Omicron. How did this happen?

Patient sitting on a couch speaking to doctor

COVID-19 Glossary: Terms to Know

See definitions for words commonly used by professionals when discussing COVID-19.

COVID-19 News

Jun 14 2022

Media Statement: Labcorp Receives FDA Emergency Use Authorization for First COVID-19 Test to Identify Specific SARS-CoV-2 Lineages

BURLINGTON, N.C.,  June 14, 2022 — On Friday, June 10, 2022, Labcorp, a global life sciences company, received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its VirSeq SARS-CoV-2 NGS (next-generation sequencing) Test on the PacBio Sequel II sequencing system.

Read more about Media Statement: Labcorp Receives FDA Emergency Use Authorization for First COVID-19 Test to Identify Specific SARS-CoV-2 Lineages

View our latest news about advancements in health science, COVID-19, and more.

View more COVID-19 News

Labcorp's COVID-19 PCR Testing

1-2 Days

Average Time to Result from Specimen Pickup


Molecular Tests Performed


Molecular Test Capacity Per Day*


Antibody Tests Performed


Antibody Test Capacity Per Day*


Tests Offered with No Upfront Costs**

Tracking COVID-19 Variants

Labcorp has been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants. We have been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19. Our tests remain effective against variants like Omicron and Delta. This is because they are designed to identify segments of the genetic code that are the least likely to mutate. For more information on variants, see our Viral Variation 101 post or read our Guide to Variants.

Total number of samples sequenced

402,000 as of June 30, 2022

Data covers the U.S. including the District of Columbia and Puerto Rico

Labcorp PCR Test performance confirmed

Alpha (B.1.1.7, Q.1-Q.8)

Beta (B.1.351, B.1.351.2, B.1.351.3)

Delta (B.1.617.2)

Epsilon (B.1.427, B.1.429)

Eta (B.1.525)

Gamma (P.1, P.1.1, P.1.2) 

Iota (B.1.526)

Kappa (B.1.617.1)

Lambda (C.37)

Mu (B.1.621)

Omicron (B.1.1.529, BA.2, BA.4, BA.5)

Zeta (P.2)

For more information visit US COVID-19 Cases Caused by Variants on the CDC website.